Skip to content

Evaluation of the safety and efficacy of Doctive® lollipop in the treatment of Denture Stomatitis

Evaluation of the safety and efficacy of Doctive® for the treatment of Denture Stomatitis: a randomized double-blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-5yzdx8g
Enrollment
Unknown
Registered
2024-10-18
Start date
2024-12-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis, Denture

Interventions

This is a randomized, controlled, double-blind, single-center, two-arm clinical study. Neither the researchers who will evaluate the outcomes nor the statistical analyst will be aware of which group e
2. After washing it well with running water and mild soap
and 3. At night (sleeping period) remove the denture and place i

Sponsors

Faculdade de Odontologia da Universidade Federal de Goiás
Lead Sponsor
Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients using upper total dentures (PT) with a clinical diagnosis of Denture Stomatitis; over 18 years old; both sexes; with autonomy and ability to understand the purpose of the treatment and availability to voluntarily collaborate with the research

Exclusion criteria

Exclusion criteria: Patients allergic to any component of the DOCTIVE® formulation; immunocompromised; who have recently made continuous use of systemic or topical intraoral antifungals; patients who have recently made use of broad-spectrum antibiotics

Design outcomes

Primary

MeasureTime frame
It is expected to find improvement or worsening of the signs and symptoms of Denture Stomatitis

Secondary

MeasureTime frame
To evaluate the cost-effectiveness of Doctive® compared to the use of nystatin in the treatment of Denture Stomatitis

Countries

Brazil

Contacts

Public ContactNádia do Lago Costa

Universidade Federal de Goiás

nadia_costa@ufg.br+55(62)32096051

Outcome results

None listed

Source: REBEC (via WHO ICTRP)